Based on 2 analysts offering 12 month price targets for Can Fite Biopharma Ltd
Min Forecast
$10.00+784.96%
Avg Forecast
$14.00+1,138.94%
Max Forecast
$18.00+1,492.92%
Should I buy or sell CANF stock?
Based on 2 analysts offering ratings for Can Fite Biopharma Ltd.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CANF's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CANF as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their CANF stock forecasts and price targets.
Is Can Fite Biopharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSEMKT: CANF) stock is to Strong Buy CANF stock.
Out of 2 analysts, 1 (50%) are recommending CANF as a Strong Buy, 1 (50%) are recommending CANF as a Buy, 0 (0%) are recommending CANF as a Hold, 0 (0%) are recommending CANF as a Sell, and 0 (0%) are recommending CANF as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year CANF price target, the average CANF price target is $14.00, with the highest CANF stock price forecast at $18.00 and the lowest CANF stock price forecast at $10.00.
On average, Wall Street analysts predict that Can Fite Biopharma's share price could reach $14.00 by Apr 15, 2026. The average Can Fite Biopharma stock price prediction forecasts a potential upside of 1,138.94% from the current CANF share price of $1.13.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.